Barclays Lowers Church & Dwight (NYSE:CHD) Price Target to $82.00

Church & Dwight (NYSE:CHD) had its target price decreased by equities researchers at Barclays from $83.00 to $82.00 in a report issued on Monday, Benzinga reports. The firm presently has an “underweight” rating on the stock. Barclays‘s price objective would indicate a potential downside of 23.31% from the stock’s current price.

Other equities analysts have also recently issued reports about the stock. Oppenheimer boosted their price objective on shares of Church & Dwight from $110.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, April 23rd. JPMorgan Chase & Co. reduced their price objective on shares of Church & Dwight from $98.00 to $97.00 and set an “underweight” rating for the company in a research report on Friday, May 3rd. Evercore ISI raised their price target on Church & Dwight from $107.00 to $110.00 and gave the company an “in-line” rating in a report on Friday, May 3rd. The Goldman Sachs Group initiated coverage on Church & Dwight in a research report on Friday, March 1st. They issued a “buy” rating and a $110.00 price objective for the company. Finally, HSBC raised their price objective on shares of Church & Dwight from $110.00 to $114.00 and gave the company a “hold” rating in a research note on Friday, May 3rd. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $105.56.

Church & Dwight Stock Performance

Shares of CHD opened at $106.92 on Monday. The stock has a 50-day simple moving average of $103.92 and a 200-day simple moving average of $98.11. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.82 and a current ratio of 1.33. Church & Dwight has a 1 year low of $82.25 and a 1 year high of $108.68. The stock has a market capitalization of $26.14 billion, a PE ratio of 33.94, a PEG ratio of 3.53 and a beta of 0.51.

Church & Dwight (NYSE:CHD) last released its quarterly earnings data on Thursday, May 2nd. The company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.86 by $0.10. The business had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.49 billion. Church & Dwight had a return on equity of 20.35% and a net margin of 13.13%. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.85 EPS. On average, analysts predict that Church & Dwight will post 3.46 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, EVP Michael Read sold 4,500 shares of Church & Dwight stock in a transaction on Monday, March 11th. The shares were sold at an average price of $105.00, for a total transaction of $472,500.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Church & Dwight news, EVP Michael Read sold 4,500 shares of the business’s stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $105.00, for a total value of $472,500.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Penry W. Price sold 7,752 shares of the firm’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $105.47, for a total transaction of $817,603.44. Following the completion of the transaction, the director now directly owns 25,692 shares of the company’s stock, valued at approximately $2,709,735.24. The disclosure for this sale can be found here. Insiders sold a total of 371,524 shares of company stock valued at $38,491,358 over the last three months. Company insiders own 1.40% of the company’s stock.

Institutional Investors Weigh In On Church & Dwight

A number of institutional investors have recently made changes to their positions in the company. JPMorgan Chase & Co. raised its position in shares of Church & Dwight by 89.1% in the third quarter. JPMorgan Chase & Co. now owns 6,027,312 shares of the company’s stock valued at $552,283,000 after buying an additional 2,839,783 shares in the last quarter. Norges Bank bought a new stake in shares of Church & Dwight during the 4th quarter valued at $259,967,000. Capital International Investors lifted its position in shares of Church & Dwight by 39.2% during the 4th quarter. Capital International Investors now owns 9,004,713 shares of the company’s stock valued at $851,414,000 after acquiring an additional 2,533,877 shares during the period. Vanguard Group Inc. grew its holdings in shares of Church & Dwight by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 30,265,072 shares of the company’s stock worth $2,861,865,000 after purchasing an additional 354,946 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its position in shares of Church & Dwight by 26.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,334,950 shares of the company’s stock worth $126,233,000 after purchasing an additional 277,017 shares during the period. Institutional investors own 86.60% of the company’s stock.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.